REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioGend Therapeutics Co., Ltd. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

BioGend Therapeutics Co., Ltd. is mainly engaged in the development of bone and cartilage repair. The company was founded in 2016 and is headquartered in New Taipei City, Taiwan.

Headquarters
4F, No.3-2, Yuang St.Nangang District
Taipei City; Taipei City;

Contact Details: Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.

Website: http://www.biogend.com.tw

Basic Information
Total Employees:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Outstanding Shares:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Financial Auditors:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Incorporation Date:
July 07, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
30.53%
Purchase this report to view the information.
3.08%
Purchase this report to view the information.
0.66%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
山東博升生物技術有限公司
100%
Osteopharma Inc. (Japan)
46.73%
Company Performance
Financial values in the chart are available after BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
37.59%▲
Total operating revenue
37.44%▲
Operating profit (EBIT)
-14.66%▼
EBITDA
-28.92%▼
Net Profit (Loss) for the Period
-15.39%▼
Total assets
-13.06%▼
Total equity
-13.42%▼
Operating Profit Margin (ROS)
14.11%▲
Net Profit Margin
11.98%▲
Return on Equity (ROE)
-1.98%▼
Debt to Equity Ratio
-0.28%▼
Quick Ratio
-8.53%▼
Cash Ratio
0.85%▲

Similar companies

Bora Pharmaceuticals Co., Ltd.
 
Lotus Pharmaceutical Co., Ltd.
Great Tree Pharmacy Co.,Ltd.
 
PharmaEssentia Corp.
Cenra Inc.
 
China Chemical & Pharmaceutical Co., Ltd
Tensall Bio-Tech Co., Ltd.
 
Taigen Biopharmaceuticals Holdings Limit
Formosa Pharmaceuticals, Inc.
 
Pet Pharm Biotech Co. Ltd.
Holy Stone Healthcare Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo